About Hygieia Shenzhen Hygieia Biotechnology Co., Ltd.??focuses on the R & D, production and sales of new dietary supplement raw materials. In 2019, we realized the industrialization of high-purity Nicotinamide Mononucleotide (NMN) based on a new enzymatic process, with a number of independent intellectual property rights. In the future, Hygieia will introduce computer AI-design technology into protein artificial assembly, and combine with new enzyme engineering technology to achieve more technological breakthroughs. In addition, we actively participate in the research projects with domestic and foreign research institutions, help promote the progress of NMN in clinical research, continuously expand the research of NMN application and explore related indications, and provide more basic research data support for NMN industry chain! We focus on anti-aging, focus on health, and share the future with you!